U.S. to buy Siga's IV drug worth $26 million to fight monkeypox outbreak

U.S. to buy Siga's IV drug worth $26 million to fight monkeypox outbreak The U.S. government will buy Siga Technologies Inc's $26-million worth of intravenous formulation of antiviral drug Tpoxx, the company said on Tuesday, as the country fights an outbreak of monkeypox cases. Reuters Reuters

...

The company plans to deliver by next year the order for the IV treatment, which would be a vital option for patients unable to swallow the oral pill as monkeypox symptoms include rashes and blisters in the mouth...